Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioprotection of EMT6 tumor by a new class of radioprotectors based on a pseudo-peptide cysteamine combination. [Mice]

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Although WR-2721 preferentially protects normal tissues against irradiation, it seemed desirable to find other drugs presenting a lower toxicity and the same radioprotective properties. A new compound, I 102, was selected; it was characterized on one hand by a coupling between cysteamine and an amino-acid, and on the other hand by an acetyl-group, which protects the thiol function. The effects of WR-2721 and of I 102 were studied on EMT6 tumors grafted on BALB/c mice. Whatever the size of the tumor, the cell survival increased as a function of the time elapsed between the injection of I 102 and the end of the irradiation (TI). In contrast, the radioprotection afforded by WR-2721 was found to be independent of Tl. The survival curves suggest that, like WR-2721, I 102 protects essentially oxygenated cells.
Research Organization:
Institut Gustave-Roussy, Villejuif, France
OSTI ID:
5436288
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 11:5; ISSN IOBPD
Country of Publication:
United States
Language:
English

Similar Records

Radiobiological evaluation of a newly synthesized cysteamine derivative
Journal Article · Fri Aug 01 00:00:00 EDT 1986 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6933940

Comparative study of the radioprotective effects of cysteamine, WR-2721, and WR-1065 in cultured human cells. [Reproductive death of cells following. gamma. irradiation used as indicator]
Journal Article · Wed Jan 31 23:00:00 EST 1979 · Radiat. Res.; (United States) · OSTI ID:6312192

Induction of marrow hypoxia by radioprotective agents
Technical Report · Sat Dec 31 23:00:00 EST 1988 · OSTI ID:7018562